--------------------------- cut here ----------------------------------
CARNIVORA.
It sounds like something drempt up in a grade-D science-fiction movie. While
watching the Venus flytrap plants in his wife's window boxes digest protein
tissues such as flies, insects, and small worms, German physician Helmut
Keller got his brainstorm. Impressed with the plant's voracity, he decided
to test its pressed juices in animal and in vitro studies. "Carnivora proved
to be extremely nontoxic and nonmutagenic," Keller asserts, and its effects
included cytostasis (the destruction of cancer cells), immune enhancement,
mitotic (cancer-cell division) inhibition, virucidal (virus-killing)
effects, and pain relief. Then along came human patients.
Since 1981, Carnivora, an extract of the meat-eating Venus flytrap plant
(_Dionaea muscipula_), has been used on over 2,000 patients, allegedly
including former president Ronald Reagan. In Keller's native Germany, it's
reportedly showing promise in the treatment of cancer, AIDS, and other
immune-compromised conditions. In an initial clinical study of 210 dying
patients with a variety of cancers, all of whom had undergone unsuccessful
chemotherapy or radiation, 40 percent were stabilized by Carnivora treatment
and 16 percent went into remission. Carnivora is administered by
intramuscular injection or in the form of drops for oral and inhalation use.
Dosage and timing is prescribed on the basis of an extensive immune profile.
Access: Carnivora-Forschungs-Gmbh, Postfach 8, Lobensteiner Strasse 3,
D-8646 Nordhalben, Germany; phone: 011-49-9267-1662.
--------------------------- cut here ----------------------------------
-- Rick